stem cells

US Stem Cell Clinic sues anonymous critics for libel, seeks IDs from websites

/ / 2 Comments
stem cell stocks

Last month the stem cell community learned that a patient of the business US Stem Cell Inc./US Stem Cell Clinic, previously known as Bioheart, had filed suit in a Broward County Florida Court against the publicly traded company alleging various charges including damage to her eye. Now US Stem Cell has more recently filed suit in the […]

US Stem Cell Clinic sues anonymous critics for libel, seeks IDs from websites Read More »

Reviews of my new book GMO Sapiens on #CRISPR & human modification

/
GMO-Sapiens-Book-Cover

It’s exciting that the reviews are starting to come in on my new book, GMO Sapiens, on human genetic modification including CRISPR. Here is one from The Scientist and the book was recommended by Scientific American. Reviews from individual authors and scientists are below. “GMO Sapiens could not be more timely. New technologies like CRISPR-Cas9 gene

Reviews of my new book GMO Sapiens on #CRISPR & human modification Read More »

Historic Boston Globe editorial on FDA, stem cells & patients argues safety first

/ / 26 Comments
Stem-Cell-Medicine

For the first time I have ever seen in at least half a dozen years, a major newspaper in the form of The Boston Globe has published an editorial on FDA regulation of stem cells. The editorial, entitled “It should be safety-first on stem cell therapies”, argues that while we should take patient concerns into

Historic Boston Globe editorial on FDA, stem cells & patients argues safety first Read More »

FDA meeting on stem cell regs: mostly who’s who of anti-regulation forces

/ / 16 Comments
FDAADF

The FDA in the past year or so has issued draft guidances on regulation of stem cells that would, if finalized, make it crystal clear that what many American stem cell clinics are selling are unapproved drugs. That would be a good thing for patients who are often being put at risk by many of

FDA meeting on stem cell regs: mostly who’s who of anti-regulation forces Read More »

A new possible environmental disaster: the gene spill

/
Gene-spill

New genetic modification technology such as CRISPR-Cas9 has opened the door to transformative biological research, but it has also set the table for some novel kinds of technological problems for which we aren’t at all prepared including one that I call the “gene spill”. The striking potential upsides to CRISPR paired with some of the

A new possible environmental disaster: the gene spill Read More »

ViaCyte on the Rise: First Diabetes Trial Data & Acquires BetaLogics IP

/
VC-01-post-implant-final1-e1503703572933, viacyte

Clinical research on Type I Diabetes is one of the most exciting and promising areas of stem cells and regenerative medicine for human disease. Two of the coolest companies out there in this arena have been ViaCyte and BetaLogics (owned by J&J). For more on ViaCyte see my interview with President and CEO Paul Laikind

ViaCyte on the Rise: First Diabetes Trial Data & Acquires BetaLogics IP Read More »

Subscribe to Our Newsletter

Be the first to know about the latest developments in stem cell and regenerative medicine research.